Clinical trial
Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)
NCT00081328 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00081328 |
|---|---|
| Title | Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) |
| Official title | Studies to Treat Or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Clinical Trial |
| Acronym | TODAY |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type II |
| Intervention type | Behavioral, Drug |
| Interventions | Metformin, Rosiglitazone, Lifestyle Program |
| Enrollment | 699 |
| Start date | May 1, 2004 |
| Primary completion | Feb 1, 2011 |
| Completion | Feb 1, 2014 |
| First posted | Apr 12, 2004 |
| Last update posted | Jul 30, 2021 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: